Axon Enterprise, Inc. (NASDAQ:AXON – Get Free Report) Director Matthew R. Mcbrady sold 2,000 shares of the stock in a transaction dated Friday, August 9th. The shares were sold at an average price of $364.66, for a total transaction of $729,320.00. Following the sale, the director now directly owns 4,892 shares of the company’s stock, valued at $1,783,916.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Axon Enterprise Trading Up 0.8 %
Axon Enterprise stock opened at $368.03 on Tuesday. Axon Enterprise, Inc. has a 52 week low of $189.12 and a 52 week high of $375.95. The stock has a 50-day moving average price of $302.63 and a 200 day moving average price of $297.66. The company has a quick ratio of 2.55, a current ratio of 2.91 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $27.77 billion, a price-to-earnings ratio of 107.61, a price-to-earnings-growth ratio of 6.65 and a beta of 0.95.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its quarterly earnings data on Tuesday, August 6th. The biotechnology company reported $1.20 EPS for the quarter, beating the consensus estimate of $1.02 by $0.18. The business had revenue of $504.00 million during the quarter, compared to analysts’ expectations of $478.35 million. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.73%. The business’s quarterly revenue was up 34.5% compared to the same quarter last year. During the same period in the previous year, the business posted $0.80 EPS. Sell-side analysts anticipate that Axon Enterprise, Inc. will post 2.35 EPS for the current year.
Institutional Investors Weigh In On Axon Enterprise
Several hedge funds and other institutional investors have recently added to or reduced their stakes in AXON. Norges Bank acquired a new position in shares of Axon Enterprise in the 4th quarter valued at about $195,406,000. Motley Fool Asset Management LLC lifted its holdings in Axon Enterprise by 238.7% in the first quarter. Motley Fool Asset Management LLC now owns 492,140 shares of the biotechnology company’s stock valued at $153,981,000 after acquiring an additional 346,838 shares during the period. 1832 Asset Management L.P. acquired a new position in Axon Enterprise in the first quarter valued at approximately $81,630,000. Vanguard Group Inc. grew its stake in shares of Axon Enterprise by 2.7% during the 1st quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock worth $2,547,878,000 after purchasing an additional 212,401 shares during the period. Finally, International Assets Investment Management LLC purchased a new position in shares of Axon Enterprise during the 4th quarter valued at approximately $39,907,000. 79.08% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of equities research analysts recently commented on the stock. Robert W. Baird increased their target price on shares of Axon Enterprise from $355.00 to $360.00 and gave the company an “outperform” rating in a research report on Wednesday, August 7th. Morgan Stanley increased their price objective on Axon Enterprise from $285.00 to $310.00 and gave the company an “equal weight” rating in a report on Friday, April 26th. Needham & Company LLC restated a “buy” rating and set a $400.00 target price on shares of Axon Enterprise in a research note on Wednesday, August 7th. Barclays increased their price target on Axon Enterprise from $381.00 to $387.00 and gave the company an “overweight” rating in a research note on Wednesday, August 7th. Finally, Craig Hallum raised their price target on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a report on Wednesday, August 7th. Two research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat, Axon Enterprise presently has an average rating of “Moderate Buy” and a consensus target price of $358.08.
View Our Latest Report on AXON
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Recommended Stories
Receive News & Ratings for Axon Enterprise Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Axon Enterprise and related companies with MarketBeat.com’s FREE daily email newsletter.
